Aug. 11 at 3:56 AM
$RZLV $IONQ $PATH $QUBT $MNKD RZLV remains an AI-focused speculative opportunity, IonQ advances quantum computing, UiPath benefits from enterprise automation and AI adoption, Quantum Computing Inc. remains a speculative quantum opportunity, and MannKind develops inhaled and metabolic treatments. I'm watching AI adoption, quantum commercialization, software growth, funding, and clinical progress.